We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Medivir Outsources Compound Management to BioAscent

News   Aug 23, 2017

 
Medivir Outsources Compound Management to BioAscent
 
 
Advertisement
 

RELATED ARTICLES

Drug Targets Pancreatic Tumors Harboring Mutant KRAS

News

Researchers have demonstrated that pancreatic cancer patients with mutant KRAS-addicted tumors could benefit from treatment with a CDK inhibitor.

READ MORE

Team Finds Compounds Capable of Killing Lethal Liver Cancer Cells

News

Surgery is currently the only option for fibrolamellar carcinoma. Researchers have discovered classes of therapeutics that destroy fibrolamellar tumor cells growing in mice.

READ MORE

Potential Treatment Approach for Alzheimer's Patients Carrying APOE4

News

A new study sheds light on how the APOE4 gene may instigate a cascade of pathologies that contribute to Alzheimer's disease. It also reveals a potential therapeutic target for the disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE